Luminex Revenues Surge 17 Percent in Q3 as Loss Swings to Profit | GenomeWeb
NEW YORK (GenomeWeb News) — Luminex yesterday said third-quarter revenues increased 17 percent as the company swung to a profit.
 
Total receipts for the three months ended Sept. 30 increased to $12.5 million from $10.7 million year over year.
 
The majority of the company’s revenue came from sales of its Luminex systems, about a third came from consumables, and the rest was from royalties.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.